Biography and Research Information
OverviewAI-generated summary
Luke Enemark studies the discovery of novel chemical compounds with potential therapeutic applications. His recent work focuses on 1H-pyrazolo[3,4-d]pyrimidine derivatives, investigating their efficacy as inhibitors for BRK/PTK6. This research is situated within the broader field of drug discovery and development, aiming to identify new molecular entities that can target specific biological pathways relevant to disease treatment. Enemark has co-authored two publications, collaborating with Sayem Miah at the University of Arkansas for Medical Sciences. His research output indicates recent activity in the field.
Metrics
- Publications: 2
Selected Publications
-
Discovery of novel 1H-pyrazolo[3,4-d]pyrimidine derivatives as BRK/PTK6 inhibitors (2025)
-
Discovery of Novel 1h-Pyrazolo[3,4-D]Pyrimidine Derivatives as Brk/Ptk6 Inhibitors (2025)
Collaboration Network
Top Collaborators
Baku Acharya
University of Arkansas for Medical Sciences
2 shared publications
In database
- Discovery of Novel 1h-Pyrazolo[3,4-D]Pyrimidine Derivatives as Brk/Ptk6 Inhibitors
- Discovery of novel 1H-pyrazolo[3,4-d]pyrimidine derivatives as BRK/PTK6 inhibitors
Maha Hanafi
2 shared publications
- Discovery of Novel 1h-Pyrazolo[3,4-D]Pyrimidine Derivatives as Brk/Ptk6 Inhibitors
- Discovery of novel 1H-pyrazolo[3,4-d]pyrimidine derivatives as BRK/PTK6 inhibitors
Daniel W. Armstrong
University of Arkansas for Medical Sciences
2 shared publications
In database
- Discovery of Novel 1h-Pyrazolo[3,4-D]Pyrimidine Derivatives as Brk/Ptk6 Inhibitors
- Discovery of novel 1H-pyrazolo[3,4-d]pyrimidine derivatives as BRK/PTK6 inhibitors
Debasmita Saha
2 shared publications
- Discovery of Novel 1h-Pyrazolo[3,4-D]Pyrimidine Derivatives as Brk/Ptk6 Inhibitors
- Discovery of novel 1H-pyrazolo[3,4-d]pyrimidine derivatives as BRK/PTK6 inhibitors
Sayem Miah
2 shared publications
In database
- Discovery of Novel 1h-Pyrazolo[3,4-D]Pyrimidine Derivatives as Brk/Ptk6 Inhibitors
- Discovery of novel 1H-pyrazolo[3,4-d]pyrimidine derivatives as BRK/PTK6 inhibitors
Brendan Frett
2 shared publications
In database
- Discovery of Novel 1h-Pyrazolo[3,4-D]Pyrimidine Derivatives as Brk/Ptk6 Inhibitors
- Discovery of novel 1H-pyrazolo[3,4-d]pyrimidine derivatives as BRK/PTK6 inhibitors
Similar Researchers
Based on overlapping research topics
Mallory Eggleton
University of Arkansas at Fayetteville
Cancer-related molecular mechanisms research
Protein Structure and Dynamics
Disease Mechanisms Research
Gaëtane Ternier
University of Arkansas at Fayetteville
Cancer-related molecular mechanisms research
Receptor Mechanisms and Signaling
Protein Structure and Dynamics
Mahmoud Moradi
University of Arkansas at Fayetteville
Drug Transport and Resistance Mechanisms
Computational Drug Discovery Methods
Receptor Mechanisms and Signaling
Xiuqi Wang
University of Arkansas for Medical Sciences
Drug Transport and Resistance Mechanisms
Computational Drug Discovery Methods
Receptor Mechanisms and Signaling
Emily V. Pickering
Hendrix College
Computational Drug Discovery Methods
Receptor Mechanisms and Signaling
Protein Structure and Dynamics
Jingying Zhang
University of Arkansas at Fayetteville
Drug Transport and Resistance Mechanisms
Cancer-related molecular mechanisms research
Receptor Mechanisms and Signaling